Intravitreal Bioerudivel sustained-release triamcinolone microspheres system (RETAAC). Preliminary report of its potential usefulnes for the treatment of diabetic macular edema. [electronic resource]
Producer: 20070510Description: 675-7, 679-81 p. digitalISSN:- 0365-6691
- Anti-Inflammatory Agents -- administration & dosage
- Delayed-Action Preparations
- Diabetes Complications -- drug therapy
- Drug Evaluation
- Glycolates -- administration & dosage
- Humans
- Injections
- Lactic Acid
- Macular Edema -- drug therapy
- Microspheres
- Pilot Projects
- Polyglycolic Acid
- Polylactic Acid-Polyglycolic Acid Copolymer
- Triamcinolone Acetonide -- administration & dosage
- Vitreous Body
No physical items for this record
Publication Type: Editorial
There are no comments on this title.
Log in to your account to post a comment.